Clinical Trials Directory

Trials / Completed

CompletedNCT00683033

Contingency Management for Smoking in Substance Abusers

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
51 (actual)
Sponsor
UConn Health · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Patients (N=102) who meet diagnostic criteria for alcohol, cocaine, marijuana, or opiate abuse or dependence will meet with research staff on two days for quit preparation sessions (2 per day). These sessions include testing a breath sample for evidence of smoking twice each day (separated by at least 5 hours), counseling based on Public Health Service (PHS) guidelines for quitting smoking during the second session each day, and setting a quit date. After these sessions, participants will be randomly assigned to one of two 4-week conditions: (a) standard care or (b) standard care plus prize CM for smoking abstinence with the opportunity to win prizes for submitting samples that meet smoking abstinence criteria (e.g., CO ≤ 6ppm; cotinine ≤ 30ng/mL). Nicotine withdrawal and related measures will be assessed throughout the intervention. Follow-up data will be collected through 6-months post-quit date.

Conditions

Interventions

TypeNameDescription
BEHAVIORALContingency ManagementFor 4 weeks starting on the quit date, daily brief (about 5 minutes) counseling based on public health service guidelines for quitting smoking is delivered. Expired carbon monoxide (CO) tests are conducted twice daily and urinary cotinine tests are conducted once each week. Participants earn the opportunity to win prizes for submitting samples that meet smoking abstinence criteria (e.g., CO ≤ 6ppm; cotinine ≤ 30ng/mL).
BEHAVIORALBrief smoking cessation counselingFor 4 weeks starting on the quit date, daily brief (about 5 minutes) counseling based on public health service guidelines for quitting smoking. Expired carbon monoxide tests are conducted twice daily and urinary cotinine tests are conducted once each week.

Timeline

Start date
2008-05-01
Primary completion
2010-10-01
Completion
2010-10-01
First posted
2008-05-23
Last updated
2011-11-21

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00683033. Inclusion in this directory is not an endorsement.